Prevalence of Smoking in Psychiatric Disorders (PD) and Substance Abuse Disorders (SUD) Kalman D, Morrisette SB, and George, TP Am J Addiction, 106-123,

Slides:



Advertisements
Similar presentations
The Addicted Synapse Katie Malanson.
Advertisements

Nicotine and Caffeine Chapter 12. Leaves of the Nicotiana tabacum plant Nicotine History.
Drug Addiction. History: Opiate Effects Characteristics of drug addiction: Characteristics of drug addiction: Tolerance: decreased drug effect w/ repeated.
Bitter Taste Phenotype & Oral NRT Adherence Karen Ahijevych, PhD, RN, FAAN Professor and Associate Dean for Academic Affairs.
The Effects of Smoking on Exercise Heat Tolerance
Teen Smoking Prevention
Tobacco 101:. Why are cigarettes bad for your health? Cigarettes have over 7,000 chemicals other than nicotine. Chemicals such as acetone (nail polish.
Opiate and Nicotine Addiction: Involvement of cAMP Response Element Binding Protein (CREB) Matt Wolfe
Nicotine Vaccines 6 Nicotine vaccines studied in animals 2 Nicotine vaccines in Phase I clinical trials Other vaccines –Cocaine: phase II clinical trial.
The StarNet Case Control Study Nicotine, Neurotransmission, and the Reward Pathway University of Washington Department of Genome Sciences.
ADDICTION Smoking: Biochemistry. Initiation  Nicotine nucleus accumbens  Brain reward centre  Increases dopamine in mesolimbic pathway  Ventral Tegmental.
Psychiatric Comorbidity of Smoking and Nicotine Dependence: An Epidemiologic Perspective Naomi Breslau, Ph.D. Department of Epidemiology Michigan State.
Bringing the Full Power of Science to Bear on Bringing the Full Power of Science to Bear on NIDA NATIONAL INSTITUTE ON DRUG ABUSE Drug Abuse & Addiction.
The Brain and Addiction
Tobacco (The Facts on Teen Smoking) HS million kids are established smokers 2.7 million kids are established smokers 16.5 million kids, including.
1 Common Features of Addiction Physical versus Psychological Addiction Tolerance: The fact that increasingly large doses of drugs must be taken to achieve.
Director, National Institute on Drug Abuse National Institute Alcohol
The Four Stages of Nicotine Addiction Starship Children’s Hospital Joseph R DiFranza MD University of Massachusetts Medical School.
The Pathophysiology and Clinical Course of Nicotine Addiction Joseph R DiFranza MD University of Massachusetts Medical School.
C2004 Alcohol Medical Scholars Program1 Craving Karen Drexler, M.D. Emory University School of Medicine.
Schizophrenia The Unwell Brain. Disturbance in the Neurochemistry  The first discovery in the mid 1950s was that chronic usage of large daily doses of.
Dr.farahzadi.1391 dr.farahzadi Overview of Methamphetamine Pharmacology.
Treating Tobacco Dependence in Patients with Other Addictions Richard D. Hurt, M.D. Professor of Medicine, Mayo Clinic College of Medicine Director, Nicotine.
Terrence D. Walton, MSW, CSAC Pretrial Services Agency for the
NEUROCHEMICAL EFFECTS OF STIMULANTS: Relation to their motor effects.
New Insights into Substance Use Disorders (SUD) From Brain Imaging Iliyan Ivanov. MD Mount Sinai School of Medicine Alcohol Medical Scholars Program 1.
Substance Use and Abuse Smoking. Smoking Tobacco: Who Smokes? Varies with age Gender differences Educational differences.
Multiple Neuronal Systems Thought to be Involved in Nicotine Dependence Frank Vocci, Ph.D. Director Division of Treatment Research and Development National.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Relation between alcohol abuse and impulsivity - Jayandra Chiluwal.
CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.
Copyright © 2009 Allyn & Bacon Chemicals That Harm with Pleasure This multimedia product and its contents are protected under copyright law. The following.
BRAIN IMAGING - PERSPECTIVES FOR STUDIES OF PSYCHIATRIC DISORDERS Jair C. Soares, M.D. Division of Mood and Anxiety Disorders, Dept of Psychiatry, University.
A Placebo-Controlled Trial of Selegiline Hydrochloride for Smoking Cessation Tony P. George, M.D., Jennifer Vessicchio, M.S.W., Angelo Termine, B.S., Peter.
Primary Care Conference Case Presentation: A New Smoking Cessation Treatment Option 25 October 2006 Douglas E. Jorenby, Ph.D.
Tobacco Use. What’s in Tobacco?  Tobacco contains many harmful chemicals.  It is a drug that speeds up your heart rate and affects the central nervous.
Chapter 14 Tobacco Lesson 3 Tobacco Addiction. Building Vocabulary psychological dependence A person’s belief that he or she needs a drug to feel good.
Nicotine and Caffeine Chapter 12. Leaves of the Nicotiana tabacum plant Nicotine History.
Emerging Evidence for the Role of Polymorphic Drug Metabolizing Enzymes in Smoking Behavior and Treatment Caryn Lerman & Rachel Tyndale University of Pennsylvania.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Animal Models of Ethanol and Nicotine Interactions.
Psychopharmacology psychopharmacology – study of drugs and behavior
(1)Graded potentials on the post-synaptic membrane: depolarization and hyperpolarization; ligand-gated mechanisms (2) What happens at a synapse? A.  Transmitter.
Biological Explanations for Schizophrenia
Should Smoking be Made Illegal in the United States?
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
David Perry Professor Dept. of Pharmacology & Physiology
NATIONAL INSTITUTE ON DRUG ABUSE NIDA NIAAA National Institute Alcohol Abuse and Alcoholism Nora D. Volkow, M.D. Director, National Institute on Drug Abuse.
Department of Family Medicine Smoking Cessation Counselling By: Lucie Desjardins Bscn R.N Certified Smoking Cessation Counsellor from CAMH.
11 Motivation  Nicotine causes DA release in the striatum, part of the mesolimbic DA pathway which mediates reinforcing behaviors (Martin-Soelch et al,
Smoking. What’s in a cigarette? Cigarette smoke contains over 4,000 chemicals, including: – 43 known cancer-causing (carcinogenic) compounds – 400 other.
Substance Abuse Part I: Smoking. Studies show that cigarette smoking is most likely to become a habit during the adult years. TRUE FALSE Studies show.
Varenicline: A Tale of Three Molecules Douglas E. Jorenby, Ph.D. Associate Professor of Medicine Univ. of WI School of Medicine and Public Health The Center.
1 Varenicline for smoking cessation Robert West University College London Logroño, October
Emerging Neuronal Nicotinic Receptor Targets Marina Picciotto Department of Psychiatry Yale University School of Medicine.
Lab 16. tobacco Nicotine Nicotine is the active ingredient in tobacco. Although this drug is not currently used therapeutically(except in smoking.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: γ-Aminobutyric Acid Type A Receptors and Alcoholism:
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
The Reward Pathway.
Effects of smoking on MAN
Jonathan Foulds, Jessica M. Yingst, Susan Veldheer, Shari Hrabovsky,
Use of biomarkers in smoking cessation trials
Alcohol and nicotine interactions: behavioural studies
Nicotine and nicotine withdrawal 6 quick facts for clinicians and administrators Geisel School of Medicine at Dartmouth 2015.
ABCs of Behavioral Support
Using Technology to Expand Access to Evidence-Based Therapy
Volume 19, Issue 4, Pages (April 2017)
Matthew T. Sutherland, Elliot A. Stein  Trends in Molecular Medicine 
Presentation transcript:

Prevalence of Smoking in Psychiatric Disorders (PD) and Substance Abuse Disorders (SUD) Kalman D, Morrisette SB, and George, TP Am J Addiction, , 2005

Ligand gated ion channel Pentamer α and β subunits Twelve known subunits α 2-10 and β 2-4 Two main types present in brain α 7 nAChR subtype High affinity for α- bungarotoxin α 4 β 2 nAChR subtype High affinity for nicotine Believed to upregulate in response to nicotine Nicotinic Acetylcholine Receptors (nAChR)

 2 *-nAChRs in the Reward Pathway Ventral Tegmental AreaVentral Striatum Nicotine  2 -nAChR Dopamine

High affinity for neuronal nAChRs High selectivity for nAChR with the β2 subunit Low nonspecific binding Dissociates slowly from the receptor Readily crosses the blood brain barrier Low toxicity [ 123 I]5-IA [5-iodo-3-(2(S)-azetidinylmethoxy)pyridine] Musachio 1998, 1999; Fujita 2000; Horti 1999; Mukhin 2000

Subtype Selectivity of nAChR Ligands Ligand K i nM (Ratio to K i(  4  2) ) 4242 3434 77 muscle (–)-Nicotine 0.84 (1) 100 (120) 130 (150) 1000 (1200) (  )-Epibatidine (1) (6) 4.0 (500) 7.5 (900) (  )-IPH (1) 0.11 (4) 30 (1100) 6.5 (240) 2-Fluoro-A (1) 110 (2400) 165 (3600) 360 (7800) 6-Fluoro-A (1) 10.5 (420) 170 (6500) 460 (18000) 5-Iodo-A (1) 51 (5000) 250 (25000) 1400 (140000) Mukhin,… London et al. Mol. Pharmacol. 2000

[ 123 I]5-IA SPECT measurement of  2 *-nAChR in brain (Staley et al., J Nuc Med, 2005)

Evidence nAChRs upregulate Nicotine, the primary addictive chemical in tobacco smoke, upregulates the nicotinic acetylcholine receptor (nAChR). This has been shown postmortem in human tobacco smokers (Breese et al., 1997; Court et al., 1998). Confirmed in animal studies after chronic nicotine exposure (Kassiou et al., 2001, Marks et al., 1992). Due to changes in receptor density, Bmax, as opposed to changes in receptor affinity, K D (Peng et al., 1994; Marks et al., 1983). The changes in receptor density may underlie tobacco smoking tolerance and dependence.

Urine cotinine levels (ng/mL) were measured with NicoMeter™ test strips Nicotine blocks [ 123 I]5-IA binding in nonhuman primates (Staley et al., J Neuroscience 2006)

Never Smoker (Female, 31 yo) Smoker (Female, 32 yo ), Abstinent 7 days (Staley et al., J Neuroscience 2006) Higher cortical  2 *-nAChR in abstinent smokers vs. never smokers

Evidence nAChRs normalize over time Preclinical: nicotine binding returns to control levels between 7 days and 3 weeks abstinence depending on the route of administration and dosing regimen (Marks et al., 1985; Pietila et al., 1998; Ksir et al., 1985). Postmortem: smokers who quit at least 2 months prior to death had nicotine binding levels similar to controls (Breese et al., 1997). In vivo: the upregulation was shown to be temporary, decreasing by 21 days of abstinence (Mamede et al., 2007).

The purpose was to examine  2 *-nAChR availability in tobacco smokers over the course of abstinence. STUDY 1 Smokers were scanned up to 4 times….. 1 day, 1 week, 2 weeks, 4 weeks 1 week, 4 weeks, 6-12 weeks Cosgrove…..Staley, Arch Gen Psych, 2009

Abstinence from smoking Smokers were helped to remain abstinent with contingency management techniques. Abstinence was confirmed twice daily for the first 8 days with carbon monoxide and urine cotinine measurements. Carbon monoxide levels (ppm) Urine Cotinine levels (ng/mL) Measured with NicAlert™

MRISPECT 3. Metabolism & protein binding 1. Radiotracer Synthesis 2. Radiotracer Injection 4. SPECT & STEP Scan MRI & SPECT

[ 123 I]5-IA SPECT regions of interest FC AC PC TIC FC AC Cd Pt Th OC CB FC AC Parietal Cortex Temporal Cortex Frontal Cortex Anterior Cingulate Caudate Putamen Thalamus Occipital Cortex Cerebellum Medial FC

Outcome Measure Receptor “availability” Receptors that are free or available to be bound by the radiotracer. It is not a measure of all receptors, because some could be occupied by acetylcholine or nicotine. V T /f p = radioactivity in brain /blood

Subject Characteristics 1 day~1 wks~2 wks~4 wks6-12 wks N Age Days abstinent # Cigarettes smoked /day # Years Smoked FTND Urine cotinine (ng/mL) Plasma cotinine (ng/mL) < CO on scan day

Cosgrove…..Staley, Arch Gen Psych, 2009  2 *-nAChR availability in smokers normalizes over the course of prolonged abstinence

 2 *-nAChR availability in brain during acute abstinence

 2 *-nAChR availability in brain during prolonged abstinence 20% decrease from 1-12 wk

 2 *-nAChR availability in brain over time in abstinent smokers

It takes up to 6-12 weeks for receptors to “normalize” Nonsmokers Smokers 1 Day Smokers 1 Week Smokers 2 Weeks Smokers 4 Weeks Smokers 6-12 Weeks

Relief of Negative Affect or Withdrawal/Urge to smoke Negative correlation between  2 *- nAChR availability and craving Cosgrove et al., 2009 Staley et al., 2006 CorrelateRegionCluster size T statisticr valuep value CravingParietal Cortex Postcentral Gyrus BA wk 4 wks Cerebellum

Summary Study 1 Normalization of the nAChR…….. – is prolonged in humans – varies between individuals – may be genetically-mediated